Sponsor or institution

Clinical trials and research at Starlight Cardiovascular, INC.

• 1Clinical trials
• 6NIH research projects
• 1Country

All recruiting trials (1)

• Lifeline ductus arteriosus stent for infants with ductal-dependent circulation

  The trial will test whether the Lifeline ductus arteriosus stent safely keeps the ductus arteriosus open in infants under 6 months who need ductal-dependent pulmonary blood flow.

  Recruiting at 10 sites Starlight Cardiovascular Inc · Los Angeles, California and 10 other locations · NCT07114718

NIH-funded research (6)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• Pulmonary flow restrictor for newborns with congenital heart disease

  A new device being developed to safely reduce blood flow to the lungs in babies with certain heart defects, aiming to avoid open-chest surgery.

  NIH research Starlight Cardiovascular, INC. · San Diego, UNITED STATES · NIH-11313619

• Percutaneous Flow Restrictor for Hypoplastic Left Heart Syndrome (HLHS) in newborns

  A new device-based approach aims to safely limit blood flow to the lungs in very young patients with HLHS, potentially avoiding risky open-heart surgery.

  NIH research Starlight Cardiovascular, INC. · San Diego, UNITED STATES · NIH-11292148

• Ductus Arteriosus Stent to Help Babies with Heart Defects

  A new ductus arteriosus stent designed for babies with certain heart defects could reduce the need for surgery and lower complications.

  NIH research Starlight Cardiovascular, INC. · San Diego, UNITED STATES · NIH-11243516

• Creating a new device to help babies with heart defects breathe better

  This study is testing a new, less invasive device to help babies with Hypoplastic Left Heart Syndrome by controlling blood flow to their lungs, which could help them grow stronger before needing more surgeries.

  NIH research Starlight Cardiovascular, INC. · San Diego, UNITED STATES · NIH-11059188

• A new stent to keep a vital blood vessel open in newborns with heart defects

  This study is testing a new stent designed just for newborns with heart issues to help keep an important blood vessel open, making it safer and easier for doctors to treat these tiny patients without needing more surgeries.

  NIH research Starlight Cardiovascular, INC. · San Diego, UNITED STATES · NIH-11044511

• Improving treatment for newborns with congenital heart defects using a specialized stent

  This study is working on a special stent for newborns with heart defects that need a crucial blood vessel to stay open, aiming to make it safer and more effective than the adult stents currently used, which can cause problems and extra surgeries.

  NIH research Starlight Cardiovascular, INC. · San Diego, UNITED STATES · NIH-11006856

Quick answers

How many clinical trials run by Starlight Cardiovascular, INC. are recruiting right now?

1, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →